[Synthetic oligopeptide of hepatitis D virus antigen and its clinical application].
A 27-peptide fragment derived from natural HDAg sequence was selected, identified and synthesized. It was used to develop an EIA method for detection of anti-HD. The 27-peptide possessed the similar antigenicity with the corresponding fragment of natural HDAg, and could also compete with natural HDAg for serum anti-HD. High specificity and no cross-reaction were found among the peptide and normal human sera, normal mice sera and sera positive with HAV, HBV or HCV antibody alone. 36 serum samples were identified previously, with Abbott kits with a coincident rate of 97.2%. Anti-HD was also detected in serum samples of some blood donors and patients with liver diseases and HBV infection from 1990-1992. One (0.33%) of 300 blood donors was positive (two times higher than normal ALT level in serum). 62 patients with hepatitis A and 58 patients with non-hepatitis B were anti-HD negative. 100 (11.64%) of 859 patients with HBV infection were positive: ASC 13/410 (3.17%), AH 7/63 (10.29%), CPH 1/9 (11.11%), CAH 22/121 (18.18%), SH 15/75 (20.00%), LC 23/78 (29.49%), PHC 19/89 (19.39%). The results are consistent with our previous reports.
Zheng
H
H
Department of Infectious Diseases, Southwest Hospital, Third Military Medical College, Chongqing.
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D000956:Antigens, Viral / Q000096:biosynthesis / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D003698:Hepatitis Delta Virus / Q000276:immunology*; D006801:Humans; D051379:Mice; D009842:Oligopeptides / Q000096:biosynthesis* / Q000276:immunology; D010446:Peptide Fragments / Q000096:biosynthesis
D000914:Antibodies, Viral; D000956:Antigens, Viral; D009842:Oligopeptides; D010446:Peptide Fragments